Search

everythinglearnresearchcommunity

for

Search:↓

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Monitoring for adverse effects in clinical treatments is crucial.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Fungal skin infections significantly lower patients' quality of life.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

PCOS increases the risk of heart disease and type 2 diabetes in women.

A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.

The study suggests pandemic stress might worsen or trigger hair loss problems.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Stem-cell therapy shows promise for skin conditions but needs more research.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.

Managing multiple autoimmune diseases in one patient is very challenging.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.